REG - AstraZeneca PLC - Result of AGM <Origin Href="QuoteRef">AZN.L</Origin>
RNS Number : 3240LAstraZeneca PLC24 April 2015ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2015
Results of Annual General Meeting held on 24 April 2015
AstraZeneca PLC announced the results of the voting at its Annual General Meeting today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 1 - 8 were passed as ordinary resolutions and resolutions 9 - 12 were passed as special resolutions.
RESOLUTION
VOTES FOR
% OF VOTES CAST
VOTES AGAINST
% OF VOTES CAST
VOTES CAST IN TOTAL
TOTAL VOTES CAST AS A % OF ISSUED SHARE CAPITAL
VOTES WITHHELD
1
To receive the Company's Accounts and the Reports of the Directors and Auditor for the year ended 31 December 2014
877,576,463
99.67
2,921,581
0.33
880,498,044
69.68%
10,675,935
2
To confirm dividends
886,527,613
99.66
2,986,602
0.34
889,514,215
70.40%
1,659,763
3
To re-appoint KPMG LLP, London as Auditor
876,751,815
98.61
12,397,571
1.39
889,149,386
70.37%
2,024,593
4
To authorise the Directors to agree the remuneration of the Auditor
887,495,062
99.82
1,629,520
0.18
889,124,582
70.37%
2,049,398
5a
To re-elect Leif Johansson as a Director
851,461,560
95.76
37,705,142
4.24
889,166,702
70.37%
2,007,277
5b
To re-elect Pascal Soriot as a Director
888,590,119
99.95
426,241
0.05
889,016,360
70.36%
2,157,620
5c
To re-elect Marc Dunoyer as a Director
885,602,969
99.62
3,374,856
0.38
888,977,825
70.36%
2,196,155
5d
To elect Cori Bargmann as a Director
888,638,513
99.96
351,446
0.04
888,989,959
70.36%
2,184,021
5e
To re-elect Genevive Berger as a Director
888,552,754
99.95
465,106
0.05
889,017,860
70.36%
2,156,120
5f
To re-elect Bruce Burlington as a Director
880,639,560
99.88
1,091,107
0.12
881,730,667
69.78%
9,443,312
5g
To re-elect Ann Cairns as a Director
888,587,093
99.95
465,731
0.05
889,052,824
70.36%
2,121,156
5h
To re-elect Graham Chipchase as a Director
876,994,757
99.46
4,732,631
0.54
881,727,388
69.78%
9,445,684
5i
To re-elect Jean-Philippe Courtois as a Director
880,585,784
99.87
1,137,760
0.13
881,723,544
69.78%
9,450,753
5j
To re-elect Rudy Markham as a Director
855,335,488
99.27
6,300,712
0.73
861,636,200
68.19%
29,537,348
5k
To re-elect Shriti Vadera as a Director
888,387,120
99.93
582,556
0.07
888,969,676
70.36%
2,204,192
5l
To re-elect Marcus Wallenberg as a Director
846,091,821
98.19
15,599,701
1.81
861,691,522
68.20%
29,482,025
6
To approve the Annual Report on Remuneration for the year ended 31 December 2014
739,049,685
84.11
139,601,566
15.89
878,651,251
69.54%
12,522,725
7
To authorise limited EU political donations
859,081,444
97.36
23,307,997
2.64
882,389,441
69.83%
8,784,535
8
To authorise the Directors to allot shares
808,454,239
91.14
78,551,101
8.86
887,005,340
70.20%
4,168,208
9
To authorise the Directors to disapply pre-emption rights
875,263,416
98.61
12,347,679
1.39
887,611,095
70.25%
3,562,455
10
To authorise the Company to purchase its own shares
876,130,644
98.54
13,023,264
1.46
889,153,908
70.37%
2,019,960
11
To reduce the notice period for general meetings
778,280,838
87.53
110,881,255
12.47
889,162,093
70.37%
2,011,885
12
To adopt new Articles of Association
886,456,629
99.90
900,552
0.10
887,357,181
70.23%
3,813,971
Issued capital
As at 22 April 2015, the number of issued shares of the Company was 1,263,544,938, ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all the resolutions at the AGM. In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held.
A C N Kemp
Company Secretary
24 April 2015
This information is provided by RNSThe company news service from the London Stock ExchangeENDRAGPGUQCCUPAGAC
Recent news on AstraZeneca
See all newsRCS - LHH - LHH, EZRA's AI Leadership Transformation Program
AnnouncementREG - AstraZeneca PLC - Baxdrostat met primary endpoint in Bax24 Ph3 trial
AnnouncementREG - AstraZeneca PLC - Datroway improved OS and PFS in TROPION-Breast02
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Enhertu improved IDFS in early BC in DB-05
Announcement